Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Nvidia has partnered with leading cybersecurity firms to provide real-time security protection using its accelerator and networking hardware in combination with its AI software.

Nvidia said its cybersecurity AI platform has been adopted by World Wide Technology, CrowdStrike, Check Point and Armis to protect critical infrastructure.

Armis is integrating Nvidia’s AI into its Centrix cyber exposure management platform to protect industries like energy, ...

Armis, the cyber exposure management & security company, today announced that its Armis Centrix™ platform will be enabled by NVIDIA BlueField-3 data processing units (DPUs) and, in the future, the ...

Melco Resorts & Entertainment is majority owned by Melco International Development Limited, a company listed on the Main ...

Taaffe Auctions has confirmed that the forthcoming sale at Dungannon Farmers’ Mart on Thursday 20 th February, has attracted ...

The British Army is hoping to change its procurement processes in the digital space in the wake of problems with the Morpheus ...

Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.

Technology in the mortgage market is “really fragmented”, with a range of software systems, CRM providers and lenders with ...

The FDA has granted fast track designation to amezalpat for the treatment of patients with hepatocellular carcinoma.